Elite Pharmaceuticals Stock Price Drops Below 200-Day Average

Shares of the specialty pharmaceutical company fall as it crosses below a key technical indicator.

Published on Mar. 12, 2026

Got story updates? Submit your updates here. ›

Shares of Elite Pharmaceuticals Inc. (OTCMKTS:ELTP) fell after the stock price crossed below its 200-day moving average during trading on Wednesday. The stock closed at $0.3980, with a trading volume of 653,525 shares. Elite Pharmaceuticals is a specialty pharmaceutical company focused on complex dosage forms and addressing unmet medical needs.

Why it matters

A stock's 200-day moving average is a closely watched technical indicator that can signal a potential shift in a stock's long-term trend. When a stock price falls below this level, it may indicate a bearish sentiment among investors and could lead to further declines.

The details

Elite Pharmaceuticals shares have a 200-day moving average of $0.54 and traded as low as $0.3951 on Wednesday. The company has a market capitalization of $428.64 million, a P/E ratio of 13.27, and a beta of 0.35. In its most recent quarterly earnings report, Elite Pharmaceuticals reported revenue of $31.59 million and earnings per share of $0.01.

  • Elite Pharmaceuticals stock price crossed below its 200-day moving average on Wednesday, March 12, 2026.

The players

Elite Pharmaceuticals Inc.

A U.S.-based specialty pharmaceutical company that acquires, develops and markets both branded and generic pharmaceutical products, with a focus on complex dosage forms and addressing unmet medical needs.

Got photos? Submit your photos here. ›

The takeaway

The drop in Elite Pharmaceuticals' stock price below its 200-day moving average could signal a potential shift in the long-term trend for the specialty pharmaceutical company. Investors will be closely watching to see if the stock can regain this key technical level or if further declines are in store.